Home›People›Sylvie Gregoire
SG

Sylvie Gregoire

Director and 10% owner at CervoMed. Also a director at EIP Pharma.

ExecutiveDirectorPublic company
Updated Nov 9, 2026·Latest SEC filing Jun 10, 2026·Suggest an edit

About Sylvie Gregoire

Sylvie Gregoire is a director and 10% owner at CervoMed.

Form D filings name Sylvie Gregoire as a director at EIP Pharma.

Sylvie Gregoire reports to the SEC as a director or major shareholder of 4 public companies, including Revvity (RVTY), Cubist Pharmaceuticals (CBST) and Idm Pharma (IDMI).

Sylvie Gregoire first appears on SEC filings in 2006.

Experience

This experience comes from SEC filings. The years are when the filings name Sylvie Gregoire in the role, so the role may have started earlier or lasted longer.

CervoMed Inc.
Director and 10% owner
2023 – 2026 · Public company (CRVO)
EIP Pharma, Inc.
Director
2018 – 2023 · Boston, MA
Revvity, Inc.
Director
2015 – 2023 · Public company (RVTY)
Cubist Pharmaceuticals Inc.
Director
2006 – 2010 · Public company (CBST)
Idm Pharma, Inc.
Director
2006 – 2007 · Public company (IDMI)

Key Colleagues at Startups

The people Sylvie Gregoire works with at each company, as listed on that company's latest Form D.

EIP Pharma, Inc. · Form D, Jul 20, 2023
JP
Jeff Poulton
Director
WT
William Turner
Executive officer
FZ
Frank Zavrl
Director
KB
Kelly Blackburn
Executive officer
JA
John Alam
CEO and director
MS

Sources

  1. SECEIP Pharma, Inc. Form D, filed Jul 20, 2023
  2. SECForms 3, 4 and 5 filed by Sylvie Gregoire (SEC filer 1335822)